mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2

Cell Res. 2022 Nov;32(11):1022-1025. doi: 10.1038/s41422-022-00720-z. Epub 2022 Sep 14.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2*
  • Spike Glycoprotein, Coronavirus / genetics
  • Vaccines, Synthetic
  • mRNA Vaccines

Substances

  • mRNA Vaccines
  • Vaccines, Synthetic
  • Antibodies, Viral
  • Antibodies, Neutralizing
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2